Although González de Vega et al. reported lower plasma concentrations of total Se found in Spanish patients with T2DM which might be due to decreased levels of selenoprotein P (76), the majority of other studies on Se and DM suggest that Se may increase the risk of T2DM across a wide range of exposure levels (77). This evidence concerns the gene SELENOP and type 2 diabetes mellitus.